Angioplasty system having means for identification of atherosclerotic plaque

• US 5,275,594 A
• Filed: 11/09/1990
• Issued: 01/04/1994
• Est. Priority Date: 11/09/1990
• Status: Expired due to Fees

• Current Assignee: Cardiofocus Incorporated
• Original Assignee: C.R. Bard, Inc. (Becton, Dickinson & Co)
• Inventors: Farr, Norman E., Madden, Michael, Dumont, Michael G., Baker, Glenn S.
• Primary Examiner(s): Shay, David M.
• Application Number:
  US07/611,994
• Time in Patent Office: 1,152 Days
• Field of Search: 128/395, 128/397, 128/398, 128/633, 606/2, 606/3, 606/7, 606/13-19
• US Class Current: 606/12
• CPC Class Codes: A61B 18/245 for removing obstructions in blood vessels or calculi
• CPC Class Codes: A61B 2017/00061 spectrum
• CPC Class Codes: A61B 2017/00128 related to intensity or progress of surgical action
• CPC Class Codes: A61B 2018/00345 Vascular system
• CPC Class Codes: A61B 2018/00577 Ablation
• CPC Class Codes: A61B 2018/00869 Phase
• CPC Class Codes: A61B 2018/00904 Automatic detection of target tissue
• CPC Class Codes: A61B 2018/2247 Fibre breakage detection

Abstract

An angioplasty system and method for identification and laser ablation of atherosclerotic plaque at a target site in a blood vessel includes fluorescence analysis for identification of noncalcified plaque and calcium photoemission analysis for identification of calcified plaque. Calcified plaque is identified by time domain analysis of calcium photoemission. A high energy pulsed ultraviolet laser can be used for stimulation of fluorescence and for stimulation of calcium photoemission. The system is capable of distinguishing between calcium photoemission and a defective condition of optical fibers that are used to deliver laser energy to the target site. In an another embodiment of the angioplasty system, calcium photoemission is identified during a nonablative initial portion of the laser ablation pulse. When calcium photoemission is not identified, the laser ablation pulse is terminated during the initial nonablative portion thereof.

Claims

1. An angioplasty method comprising the steps of:

directing laser energy for stimulation of fluorescence by noncalcified atherosclerotic plaque and laser energy for stimulation of photoemission by calcified atherosclerotic plaque through a laser catheter to a target site in a blood vessel, the step of directing laser energy for stimulation of photoemission including directing a laser pulse through the laser catheter;

analyzing a spectrum of the fluorescence emitted by tissue at the target site to determine whether the florescence is representative of noncalcified atherosclerotic plaque;

analyzing photoemission by tissue at the target site to determine whether the photoemission is representative of calcified atherosclerotic plaque;

directing high power laser energy through the laser catheter to the target site if the analyzing steps indicate the presence of atherosclerotic plaque; and

detecting a defective condition of an optical fiber in said laser catheter by analyzing a tim domain signal responsive to photoemission received from the laser catheter and determining if the time domain signal is representative of a defective condition of said optical fiber, the step of analyzing a time domain signal including determining an area under the time domain signal beginning a predetermined time after the start of the laser pulse and indicating a defective condition of the optical fiber when said area exceeds a predetermined value.

2. An angioplasty method as defined in claim 1 wherein the step of analyzing photoemission includes analyzing a time domain signal responsive to photoemission by calcified atherosclerotic plaque at the target site.

3. An angioplasty method as defined in claim 2 wherein the step of analyzing a time domain signal includes determining the area under the time domain signal and indicating the presence of calcified atherosclerotic plaque when said area exceeds a predetermined value.

4. An angioplasty method comprising the steps of:

directing a laser pulse for ablation of tissue and for stimulation of photoemission by calcified atherosclerotic plaque through a laser catheter to a target site in a blood vessel;

analyzing a time domain signal responsive to photoemission by tissue at the target site to determine whether the photoemission is representative of calcified atherosclerotic plaque or tissue which does not contain atherosclerotic plaque; and

terminating the laser pulse during an initial portion thereof if the time domain signal is not representative of calcified atherosclerotic plaque.